These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Buprenorphine and methadone for opioid addiction during pregnancy. Mozurkewich EL; Rayburn WF Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488 [TBL] [Abstract][Full Text] [Related]
3. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S; Martin PR Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626 [TBL] [Abstract][Full Text] [Related]
4. Substance use in pregnancy. Wong S; Ordean A; Kahan M; ; ; ; ; J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542 [TBL] [Abstract][Full Text] [Related]
5. Obstetrical and neonatal outcomes of methadone-maintained pregnant women: a canadian multisite cohort study. Ordean A; Kahan M; Graves L; Abrahams R; Kim T J Obstet Gynaecol Can; 2015 Mar; 37(3):252-257. PubMed ID: 26001872 [TBL] [Abstract][Full Text] [Related]
6. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy. Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497 [TBL] [Abstract][Full Text] [Related]
7. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191 [TBL] [Abstract][Full Text] [Related]
8. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome. Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042 [TBL] [Abstract][Full Text] [Related]
9. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series. Kakko J; Heilig M; Sarman I Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989 [TBL] [Abstract][Full Text] [Related]
10. Methadone maintenance program in a Swiss perinatal center: (I): Management and outcome of 89 pregnancies. Kashiwagi M; Arlettaz R; Lauper U; Zimmermann R; Hebisch G Acta Obstet Gynecol Scand; 2005 Feb; 84(2):140-4. PubMed ID: 15683373 [TBL] [Abstract][Full Text] [Related]
12. Treatment of opioid dependence in the setting of pregnancy. Young JL; Martin PR Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765 [TBL] [Abstract][Full Text] [Related]
13. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates. Kelty E; Hulse G Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981 [TBL] [Abstract][Full Text] [Related]
14. Methadone maintenance program in pregnancy in a Swiss perinatal center (II): neonatal outcome and social resources. Arlettaz R; Kashiwagi M; Das-Kundu S; Fauchère JC; Lang A; Bucher HU Acta Obstet Gynecol Scand; 2005 Feb; 84(2):145-50. PubMed ID: 15683374 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Perinatal Opioid Use Disorder. Boyars L; Guille C Obstet Gynecol Clin North Am; 2018 Sep; 45(3):511-524. PubMed ID: 30092925 [TBL] [Abstract][Full Text] [Related]
16. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456 [TBL] [Abstract][Full Text] [Related]